Date:11/5/2009

rward-looking statements" of Transgenomic within the meaning of the Private Securities Litigation Reform Act of 1995, which involve known and unknown risks, uncertainties and other factors that may cause our actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Forward-looking statements include, but are not limited to, those with respect to management's current views and estimates of future economic circumstances, industry conditions, company performance and financial results, including the ability of the Company to grow its involvement in the diagnostic products and services markets. The known risks, uncertainties and other factors affecting these forward-looking statements are described from time to time in Transgenomic's reports to the Securities and Exchange Commission. Any change in such factors, risks and uncertainties may cause the actual results, events and performance to differ materially from those referred to in such statements. Accordingly, the company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 with respect to all statements contained in this press release. All information in this press release is as of the date of the release and Transgenomic does not undertake any duty to update this information, including any forward-looking statements, unless required by law.

                                Transgenomic, Inc.
                            Summary Financial Results
           Unaudited Condensed Consolidated Statements of Operations
                    (Dollars in thousands except per share data)

                                Three Months Ended      Nine Months Ended
                                    September 30,          September 30,
                                    -------------          -------------
                                  2009        2008      
'/>"/>
SOURCE  Transgenomic, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 
Related biology technology :

1. Transgenomic, Inc. Reports Second Quarter 2009 Results
2. Transgenomic, Inc. Announces Appointment of New Board Members
3. Transgenomic, Inc. Reports First Quarter 2009 Results
4. Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results
5. Transgenomic, Inc. Reports Third Quarter 2008 Results
6. Transgenomic, Inc. Forms Scientific Advisory Board
7. Transgenomic, Inc. Reports Second Quarter 2007 Results
8. BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results
9. Nektar Therapeutics Reports Third Quarter 2009 Financial Results
10. Clarient Reports 2009 Third Quarter; Nine Month Results
11. Optimer Pharmaceuticals Reports Third Quarter 2009 Financial Results